Clinical characteristics and outcomes after new-onset seizure among Zambian children with HIV during the antiretroviral therapy era
dc.contributor.author | Ravishankar, Mathura | |
dc.contributor.author | Dallah, Ifunanya | |
dc.contributor.author | Mathews, Manoj | |
dc.contributor.author | Bositis, Christopher M. | |
dc.contributor.author | Mwenechanya, Musaku | |
dc.contributor.author | Kalungwana-Mambwe, Lisa | |
dc.contributor.author | Bearden, David | |
dc.contributor.author | Navis, Allison | |
dc.contributor.author | Elafros, Melissa A. | |
dc.contributor.author | Gelbard, Harris | |
dc.contributor.author | Theodore, William H. | |
dc.contributor.author | Koralnik, Igor J. | |
dc.contributor.author | Okulicz, Jason F. | |
dc.contributor.author | Johnson, Brent A. | |
dc.contributor.author | Belessiotis, Clara | |
dc.contributor.author | Ciccone, Ornella | |
dc.contributor.author | Thornton, Natalie | |
dc.contributor.author | Tsuboyama, Melissa | |
dc.contributor.author | Siddiqi, Omar K. | |
dc.contributor.author | Potchen, Michael J. | |
dc.contributor.author | Sikazwe, Izukanji | |
dc.contributor.author | Birbeck, Gretchen L. | |
dc.date.accessioned | 2022-06-01T20:30:27Z | |
dc.date.available | 2023-07-01 16:30:26 | en |
dc.date.available | 2022-06-01T20:30:27Z | |
dc.date.issued | 2022-06 | |
dc.identifier.citation | Ravishankar, Mathura; Dallah, Ifunanya; Mathews, Manoj; Bositis, Christopher M.; Mwenechanya, Musaku; Kalungwana-Mambwe, Lisa ; Bearden, David; Navis, Allison; Elafros, Melissa A.; Gelbard, Harris; Theodore, William H.; Koralnik, Igor J.; Okulicz, Jason F.; Johnson, Brent A.; Belessiotis, Clara; Ciccone, Ornella; Thornton, Natalie; Tsuboyama, Melissa; Siddiqi, Omar K.; Potchen, Michael J.; Sikazwe, Izukanji; Birbeck, Gretchen L. (2022). "Clinical characteristics and outcomes after new- onset seizure among Zambian children with HIV during the antiretroviral therapy era." Epilepsia Open (2): 315-324. | |
dc.identifier.issn | 2470-9239 | |
dc.identifier.issn | 2470-9239 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/172838 | |
dc.description.abstract | ObjectiveThis study describes clinical profiles including human immunodeficiency virus (HIV) disease history and seizure etiology among children living with HIV presenting with new-onset seizure during the era of antiretroviral therapy (ART) in Zambia. 30-day mortality and cause of death are also reported.MethodsChildren living with HIV (CLWHIV) with new-onset seizures were prospectively evaluated at one large urban teaching hospital and two non-urban healthcare facilities. Interviews with family members, review of medical records, and where needed, verbal autopsies were undertaken. Two clinicians who were not responsible for the patients’ care independently reviewed all records and assigned seizure etiology and cause of death with adjudication as needed.ResultsFrom April 2016 to June 2019, 73 children (49 urban, 24 rural) were identified. Median age was 6 years (IQR 2.2-10.0) and 39 (53%) were male children. Seizures were focal in 36 (49%) and were often severe, with 37% presenting with multiple recurrent seizures in the 24 hours before admission or in status epilepticus. Although 36 (49%) were on ART at enrollment, only 7 of 36 (19%) were virally suppressed. Seizure etiologies were infectious in over half (54%), with HIV encephalitis, bacterial meningitis, and tuberculous meningitis being the most common. Metabolic causes (19%) included renal failure and hypoglycemia. Structural lesions identified on imaging accounted for 10% of etiologies and included stroke and non-accidental trauma. No etiology could be identified in 12 (16%) children, most of whom died before the completion of clinical investigations. Twenty-two (30%) children died within 30 days of the index seizure.SignificanceDespite widespread ART roll out in Zambia, new-onset seizure in CLWHIV occurs in the setting of advanced, active HIV disease. Seizure severity/burden is high as is early mortality. Enhanced programs to assure early ART initiation, improve adherence, and address ART failure are needed to reduce the burden of neurological injury and premature death in CLWHIV. | |
dc.publisher | CIDRZ | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | neuroinfectious disease | |
dc.subject.other | pediatric neurology | |
dc.subject.other | antiretroviral therapy | |
dc.subject.other | failure of antiretroviral therapy | |
dc.subject.other | global health | |
dc.title | Clinical characteristics and outcomes after new-onset seizure among Zambian children with HIV during the antiretroviral therapy era | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Neurology and Neurosciences | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/172838/1/epi412595_am.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/172838/2/epi412595.pdf | |
dc.identifier.doi | 10.1002/epi4.12595 | |
dc.identifier.source | Epilepsia Open | |
dc.identifier.citedreference | Dore GJ, Law MG, Brew BJ. Prospective analysis of seizures occurring in human immunodeficiency virus type-1 infection. J Neuro AIDS. 1996; 1 ( 4 ): 59 – 69. | |
dc.identifier.citedreference | Leone M, Grisold W, Kissani N, Tedeschi G, Marazzi MC. The double burden of epilepsy and HIV in sub-Saharan Africa calls for a more suitable medical education. Neurol Sci. 2021; 43 ( 2 ): 1475 – 77. https://doi.org/10.1007/s10072-021-05762-6 | |
dc.identifier.citedreference | Mbewe EG, Kabundula PP, Mwanza-Kabaghe S, et al. Socioeconomic status and cognitive function in children with HIV: evidence from the HIV-associated neurocognitive disorders in Zambia (HANDZ) study. J Acquir Immune Defic Syndr. 2022; 89 ( 1 ): 56 – 63. https://doi.org/10.1097/QAI.0000000000002825 | |
dc.identifier.citedreference | Buda A, Dean O, Adams HR, et al. Neurocysticercosis among Zambian children and adolescents with human immunodeficiency virus: a geographic information systems approach. Pediatr Neurol. 2020; 102: 36 – 43. https://doi.org/10.1016/j.pediatrneurol.2019.07.017 | |
dc.identifier.citedreference | Thakur KT, Mateyo K, Hachaambwa L, et al. Lumbar puncture refusal in sub-Saharan Africa: a call for further understanding and intervention. Neurology. 2015; 84 ( 19 ): 1988 – 90. https://doi.org/10.1212/WNL.0000000000001561 | |
dc.identifier.citedreference | Saylor D, Elafros M, Bearden D, et al. Factors associated with Lumbar puncture performance in Zambia. Am J Trop Med Hyg. 2021; 105 ( 5 ): 1429 – 33. https://doi.org/10.4269/ajtmh.21-0091 | |
dc.identifier.citedreference | Elafros MA, Belessiotis-Richards C, Birbeck GL, Bond V, Sikazwe I, Kvalsund MP. A qualitative study of patient, caregiver, doctor and nurse views of factors influencing lumbar puncture uptake in Zambia. Trans R Soc Trop Med Hyg. 2021; 0: 1 – 6. https://doi.org/10.1093/trstmh/trab124 | |
dc.identifier.citedreference | Elafros MA, Belessiotis C, Birbeck GL, Bond V, Sikazwe I, Kvalsund MP. Lumbar puncture-related knowledge, attitudes, and practices among patients, caregivers, doctors, and nurses in Zambia. Am J Trop Med Hyg. 2021; 104 ( 5 ): 1925 – 31. https://doi.org/10.4269/ajtmh.20-0509 | |
dc.identifier.citedreference | Nyogea D, Mtenga S, Henning L, et al. Determinants of antiretroviral adherence among HIV positive children and teenagers in rural Tanzania: a mixed methods study. BMC Infect Dis. 2015; 15: 28. https://doi.org/10.1186/s12879-015-0753-y | |
dc.identifier.citedreference | Biadgilign S, Deribew A, Amberbir A, Deribe K. Barriers and facilitators to antiretroviral medication adherence among HIV-infected paediatric patients in Ethiopia: a qualitative study. SAHARA J. 2009; 6 ( 4 ): 148 – 54. https://doi.org/10.1080/17290376.2009.9724943 | |
dc.identifier.citedreference | Sikazwe I, Elafros MA, Bositis CM, et al. HIV and new onset seizures: slipping through the cracks in HIV care and treatment. HIV Med. 2016; 17 ( 2 ): 118 – 23. https://doi.org/10.1111/hiv.12283 | |
dc.identifier.citedreference | Haberer JE, Cook A, Walker AS, et al. Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects. PLoS One. 2011; 6 ( 4 ): e18505. https://doi.org/10.1371/journal.pone.0018505 | |
dc.identifier.citedreference | CIDRZ. Zambia Attains 90:90:90 UNAIDS HIV/AIDS Epidemic Control Targets. Lusaka, Zambia: CIDRZ; 2022. http://www.cidrz.org/2020/12/02/zambia-attains-909090-unaids-hiv-aids-epidemic-control-targets/ | |
dc.identifier.citedreference | Jakubowski A, Stearns SC, Kruk ME, Angeles G, Thirumurthy H. The US President’s Malaria Initiative and under-5 child mortality in sub-Saharan Africa: a difference-in-differences analysis. PLoS Med.. 2017; 14 ( 6 ): e1002319. https://doi.org/10.1371/journal.pmed.1002319 | |
dc.identifier.citedreference | Holtzman DM, Kaku DA, So YT. New-onset seizures associated with human immunodeficiency virus infection: causation and clinical features in 100 cases. Am J Med. 1989; 87 ( 2 ): 173 – 7. | |
dc.identifier.citedreference | Garg RK. HIV infection and seizures. Postgrad Med J. 1999; 75 ( 885 ): 387 – 90. | |
dc.identifier.citedreference | Teja VD, Talasila SR, Vemu L. Neurologic manifestations of HIV infection: an Indian hospital-based study. AIDS Read. 2005; 15 ( 3 ): 139 – 43, C3. | |
dc.identifier.citedreference | Patterson JL, Carapetian SA, Hageman JR, Kelley KR. Febrile seizures. Pediatr Ann. 2013; 42 ( 12 ): 249 – 54. https://doi.org/10.3928/00904481-20131122-09 | |
dc.identifier.citedreference | Birbeck GL, Kalichi EM. Epilepsy prevalence in rural Zambia: a door-to-door survey. Trop Med Int Health. 2004; 9 ( 1 ): 92 – 5. https://doi.org/10.1046/j.1365-3156.2003.01149.x | |
dc.identifier.citedreference | Chomba E, Taylor TE, Hauser WA, Wasterlain C, Organek N, Birbeck GL. Seizure recurrence in rural Zambian children admitted with febrile seizures. Open J Trop Med. 2008; 1: 101 – 7. | |
dc.identifier.citedreference | Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009; 42 ( 2 ): 377 – 81. https://doi.org/10.1016/j.jbi.2008.08.010 | |
dc.identifier.citedreference | Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019; 95: 103208. https://doi.org/10.1016/j.jbi.2019.103208 | |
dc.identifier.citedreference | Potchen MJ, Kampondeni SD, Ibrahim K, et al. NeuroInterp: a method for facilitating neuroimaging research on cerebral malaria. Neurology. 2013; 81 ( 6 ): 585 – 8. | |
dc.identifier.citedreference | Nsanzimana S, Kanters S, Mills E. Towards test and treat strategy for HIV in sub-Saharan Africa. BMJ. 2015; 351: h6839. https://doi.org/10.1136/bmj.h6839 | |
dc.identifier.citedreference | Birbeck GL, French JA, Perucca E, et al. Antiepileptic drug selection for people with HIV/AIDS: evidence-based guidelines from the ILAE and AAN. Epilepsia. 2012; 53 ( 1 ): 207 – 14. https://doi.org/10.1111/j.1528-1167.2011.03335.x | |
dc.identifier.citedreference | Birbeck GL, French JA, Perucca E, et al. Evidence-based guideline: antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy. Neurology. 2012; 78 ( 2 ): 139 – 45. https://doi.org/10.1212/WNL.0b013e31823efcf8 | |
dc.identifier.citedreference | Romanelli F, Jennings HR, Nath A, Ryan M, Berger J. Therapeutic dilemma: the use of anticonvulsants in HIV-positive individuals. Neurology. 2000; 54 ( 7 ): 1404 – 7. https://doi.org/10.1212/wnl.54.7.1404 | |
dc.identifier.citedreference | Ubesie AC. Pediatric HIV/AIDS in sub-Saharan Africa: emerging issues and way forward. Afr Health Sci. 2012; 12 ( 3 ): 297 – 304. https://doi.org/10.4314/ahs.v12i3.8 | |
dc.identifier.citedreference | UNAIDS Data 2020. 2020. Available from https://www.unaids.org/sites/default/files/media_asset/2020_aids-data-book_en.pdf. Accessed March 2022. | |
dc.identifier.citedreference | Siddiqi O, Birbeck GL. Safe treatment of seizures in the setting of HIV/AIDS. Curr Treat Options Neurol. 2013; 15 ( 4 ): 529 – 43. https://doi.org/10.1007/s11940-013-0237-6 | |
dc.identifier.citedreference | Madhi SA, Madhi A, Petersen K, Khoosal M, Klugman KP. Impact of human immunodeficiency virus type 1 infection on the epidemiology and outcome of bacterial meningitis in South African children. Int J Infect Dis. 2001; 5 ( 3 ): 119 – 25. | |
dc.identifier.citedreference | Wilmshurst JM, Burgess J, Hartley P, Eley B. Specific neurologic complications of human immunodeficiency virus type 1 (HIV-1) infection in children. J Child Neurol. 2006; 21 ( 9 ): 788 – 94. | |
dc.identifier.citedreference | Bearden D, Steenhoff AP, Dlugos DJ, et al. Early antiretroviral therapy is protective against epilepsy in children with human immunodeficiency virus infection in Botswana. J Acquir Immune Defic Syndr. 2015; 69 ( 2 ): 193 – 9. https://doi.org/10.1097/QAI.0000000000000563 | |
dc.identifier.citedreference | Levy RM, Bredesen DE. Central nervous system dysfunction in acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr (1988). 1988; 1 ( 1 ): 41 – 64. | |
dc.identifier.citedreference | Siddiqi OK, Elafros MA, Bositis CM, et al. New-onset seizure in HIV-infected adult Zambians: a search for causes and consequences. Neurology. 2017; 88 ( 5 ): 477 – 82. https://doi.org/10.1212/WNL.0000000000003538 | |
dc.working.doi | NO | en |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.